https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-28 / Korean J. Physiol. Pharmacol. 2010 Feb;14(1):11-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-28 / Korean J. Physiol. Pharmacol. 2010 Feb;14(1):11-42010-02-28 00:00:002019-02-15 08:47:49Dendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-24 / Cell. Immunol. 2010;263(1):9-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-24 / Cell. Immunol. 2010;263(1):9-212010-02-24 00:00:002019-02-15 08:50:11Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-18 / Am. J. Respir. Crit. Care Med. 2010 Jun;181(12):1383-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-18 / Am. J. Respir. Crit. Care Med. 2010 Jun;181(12):1383-902010-02-18 00:00:002020-09-07 08:01:07Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-10 / J Hematol Oncol 2010 Feb;3:7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-10 / J Hematol Oncol 2010 Feb;3:72010-02-10 00:00:002010-02-10 00:00:00Ovarian cancer immunotherapy: opportunities, progresses and challenges
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-09 / Immunol. Cell Biol. 2010 Jul;88(5):596-604
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-09 / Immunol. Cell Biol. 2010 Jul;88(5):596-6042010-02-09 00:00:002019-02-15 08:44:06Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-04 / Cancer Immunol. Immunother. 2010 Jul;59(7):989-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-04 / Cancer Immunol. Immunother. 2010 Jul;59(7):989-992010-02-04 00:00:002019-02-15 09:21:48The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-03 / Int J Radiat Oncol Biol Phys 2010 Nov;78(3):828-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-03 / Int J Radiat Oncol Biol Phys 2010 Nov;78(3):828-352010-02-03 00:00:002010-02-03 00:00:00Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-01 / J. Immunother. 2010 Feb-Mar;33(2):155-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-01 / J. Immunother. 2010 Feb-Mar;33(2):155-662010-02-01 00:00:002019-02-15 08:44:00Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28
